KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 71 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $113,436 | -47.0% | 14,432 | +61.8% | 0.00% | -100.0% |
| Q2 2021 | $214,000 | -64.9% | 8,919 | -62.4% | 0.00% | -75.0% |
| Q1 2021 | $610,000 | +238.9% | 23,741 | +59.8% | 0.00% | +33.3% |
| Q2 2020 | $180,000 | -69.0% | 14,853 | -80.4% | 0.00% | -80.0% |
| Q1 2020 | $581,000 | -73.5% | 75,910 | -38.3% | 0.02% | +15.4% |
| Q4 2019 | $2,191,000 | +52.5% | 123,043 | -0.7% | 0.01% | 0.0% |
| Q3 2019 | $1,437,000 | -8.9% | 123,887 | +73.9% | 0.01% | -13.3% |
| Q2 2019 | $1,578,000 | – | 71,244 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,810,246 | $17,432,669 | 7.30% |
| TCG Crossover Management, LLC | 3,395,495 | $32,698,617 | 4.82% |
| TANG CAPITAL MANAGEMENT LLC | 3,440,345 | $33,130,522 | 4.68% |
| VR Adviser, LLC | 2,916,667 | $28,087,503 | 2.96% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $31,190,212 | 2.07% |
| Nan Fung Group Holdings Ltd | 234,573 | $2,258,938 | 1.83% |
| DAFNA Capital Management LLC | 605,532 | $5,831,273 | 1.81% |
| Opaleye Management Inc. | 500,000 | $4,815,000 | 1.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 530,400 | $5,107,752 | 1.55% |
| MPM BioImpact LLC | 577,958 | $5,565,736 | 1.49% |